PTSM: Pharmaceutical Technology Sourcing and Management-05-05-2010

The traditional lines of demarcation between innovator-drug and generic-drug companies are blurring as each sector responds to changing industry fundamentals.

Further consolidation, slowing growth in established markets, and growth in smaller and emerging markets are important factors influencing the direction of the global generic-drug market.

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.